http://articles.mercola.com/sites/articles/archive/2001/08/29/diabetes-part-six.aspxLetters to physicians from the Food and Drug Administration (FDA) and warning labels included with the type 2 diabetes medication Rezulin did little to persuade doctors to routinely evaluate liver enzyme levels in patients taking the medication, accordingenCommunityServer 2008.5 SP1 (Build: 31106.3070)